932 tracked 13F filers disclose a position in GSK as of the latest SEC 13F filings, a combined $18.4B in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | $3.7B | 67.7M | ▲+0.3% Added · +192K sh | Q1 2026 | |
| 2 | DODGE & COX | $3.2B | 58.7M | ▼−14% Reduced · −9.9M sh | Q1 2026 | |
| 3 | Fisher Asset Management, LLC | $1.9B | 34.5M | ▲+4.0% Added · +1.3M sh | Q1 2026 | |
| 4 | PRIMECAP MANAGEMENT CO/CA/ | $1.4B | 25.2M | ▲+0.3% Added · +74K sh | Q1 2026 | |
| 5 | MORGAN STANLEY | $608.8M | 11.0M | ▲+89% Added · +5.2M sh | Q1 2026 | |
| 6 | GOLDMAN SACHS GROUP INC | $529.2M | 9.6M | ▲+32% Added · +2.3M sh | Q1 2026 | |
| 7 | ROYAL BANK OF CANADA | $414.3M | 7.5M | ▼−11% Reduced · −974K sh | Q1 2026 | |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | $404.1M | 7.3M | ▼−7.2% Reduced · −572K sh | Q1 2026 | |
| 9 | STATE STREET CORP | $315.1M | 6.0M | ▼−0.7% Reduced · −39K sh | Q2 2026 | |
| 10 | Holocene Advisors, LP | $304.6M | 5.5M | ▼−32% Reduced · −2.6M sh | Q1 2026 | |
| 11 | Mondrian Investment Partners LTD | $275.3M | 5.0M | ▼−14% Reduced · −820K sh | Q1 2026 | |
| 12 | BANK OF MONTREAL /CAN/ | $256.1M | 4.6M | ▲+78% Added · +2.0M sh | Q1 2026 | |
| 13 | Grantham, Mayo, Van Otterloo & Co. LLC | $188.7M | 3.6M | ▲+2.2% Added · +77K sh | Q2 2026 | |
| 14 | BlackRock, Inc. | $196.0M | 3.6M | ▲+96% Added · +1.7M sh | Q1 2026 | |
| 15 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $192.2M | 3.5M | ▼−4.8% Reduced · −176K sh | Q1 2026 | |
| 16 | EQUITY INVESTMENT CORP | $171.4M | 3.3M | ▲+1.5% Added · +49K sh | Q2 2026 | |
| 17 | Connor, Clark & Lunn Investment Management Ltd. | $145.1M | 2.8M | ▼−1.8% Reduced · −50K sh | Q2 2026 | |
| 18 | DIMENSIONAL FUND ADVISORS LP | $142.8M | 2.6M | ▲+3.5% Added · +87K sh | Q1 2026 | |
| 19 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | $131.2M | 2.4M | ▼−35% Reduced · −1.3M sh | Q1 2026 | |
| 20 | SEI INVESTMENTS CO | $126.2M | 2.3M | ▲+40% Added · +654K sh | Q1 2026 | |
| 21 | BANK OF AMERICA CORP /DE/ | $121.8M | 2.2M | ▼−41% Reduced · −1.5M sh | Q1 2026 | |
| 22 | UBS Group AG | $115.0M | 2.1M | ▼−67% Reduced · −4.2M sh | Q1 2026 | |
| 23 | ENVESTNET ASSET MANAGEMENT INC | $101.4M | 1.8M | ▼−31% Reduced · −807K sh | Q1 2026 | |
| 24 | NORTHERN TRUST CORP | $96.5M | 1.7M | ▲+2.8% Added · +48K sh | Q1 2026 | |
| 25 | BNP PARIBAS FINANCIAL MARKETS | $93.7M | 1.7M | ▲+351% Added · +1.3M sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 4 funds opened a new position in GSK and 23 added to an existing one, while 23 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| MICROSOFT CORPMSFT | 573 funds | $258.2B |
| ALPHABET INC-CL AGOOGL | 562 funds | $165.6B |
| APPLE INCAAPL | 557 funds | $274.9B |
| AMAZON.COM INCAMZN | 554 funds | $187.6B |
| NVIDIA CORPNVDA | 553 funds | $342.6B |
| JPMORGAN CHASE & COJPM | 549 funds | $64.0B |
| META PLATFORMS INC-CLASS AMETA | 545 funds | $100.7B |
| CHEVRON CORPCVX | 545 funds | $33.3B |
| ELI LILLY & COLLY | 540 funds | $76.4B |
| JOHNSON & JOHNSONJNJ | 539 funds | $46.4B |
| ALPHABET INC-CL CGOOG | 534 funds | $113.1B |
| BROADCOM INCAVGO | 532 funds | $136.7B |
Ranked by how many of GSK's institutional holders also hold each name, a cross-fund conviction signal.
No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.
| Class | 13F holders | Value held |
|---|---|---|
| GSKthis pagecs | 932 funds | $18.4B |
| 37733W105Stock | 6 funds | $4.5M |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
No filings captured for this ticker in the live stream yet.
Connected entities for GSK
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/GSK/capital-change-brief"
Use Arkolith's capital_change_brief for GSK. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for GSK. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.